SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...

You have strategic business objectives. We have the network and expertise to help you realize your goals. We assemble a team that works closely with you to develop a customized investment solution.
Together, we can design a tailored investment approach to support corporate or family office initiatives, market expansion objectives, business development strategies, or any other focused business goals you have in mind.